News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Daily News PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent L.A. McKeown February 11, 2025
News Industry News Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients January 30, 2025
News Conference News TCT 2024 Embolic Protection Benefits Varied by Geography in PROTECTED TAVR Todd Neale October 31, 2024
News Daily News Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge L.A. McKeown October 15, 2024
News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Conference News VIVA 2023 New Carotid Stent Systems Associated With Low Stroke Risk L.A. McKeown November 09, 2023
News Daily News BP Reduction With Renal Denervation Still Evident a Decade On Michael O'Riordan January 31, 2023
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Conference News ISC 2021 Adjustable Stent Retriever Performs Well in IDE Trial Todd Neale March 24, 2021
News Daily News Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk Todd Neale January 20, 2021
News Conference News TCT 2020 Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II Todd Neale October 15, 2020
News Daily News FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion Todd Neale July 22, 2020